Anixa Biosciences
ANIX
$2.94
Share price
-1.01%
Change (1 day)
-26.32%
Change (1 year)
Categories
Operating Margin for Anixa Biosciences (ANIX)
Operating Margin as of May 2024 (TTM): -2,561.54%
According to Anixa Biosciences's latest financial reports and stock price the company's current Operating Margin is -2,561.54%. At the end of 2021 the company had an Operating Margin of -2,561.55%.
Operating Margin history for Anixa Biosciences from 2001 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,561.55% | |
| 2019 | -4,727.46% | 269.25% |
| 2018 | -1,280.28% | -7.35% |
| 2017 | -1,381.79% | -17.36% |
| 2016 | -1,672.14% | 11122.04% |
| 2015 | -14.90% | -94.31% |
| 2014 | -261.94% | -89.9% |
| 2013 | -2,592.28% | 477.29% |
| 2012 | -449.04% | -33.54% |
| 2011 | -675.65% | -4.61% |
| 2010 | -708.27% | -54.65% |
| 2009 | -1,561.76% | 437.96% |
| 2008 | -290.31% | -72.81% |
| 2007 | -1,067.79% | -28.79% |
| 2006 | -1,499.58% | 47.68% |
| 2005 | -1,015.44% | 49.21% |
| 2004 | -680.54% | -46.71% |
| 2003 | -1,277.15% | 1902.03% |
| 2002 | -63.79% | -70.07% |
| 2001 | -213.17% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.